Exploring Microbiome-Based Therapy

Let's Talk ID

Host Paul Sax, MD, FIDSA, is joined by Libby Hohmann, MD, FIDSA, an ID specialist at Massachusetts General Hospital, director of the Fecal Microbiota Transplant Lab and associate professor of medicine at Harvard Medical School, to discuss the innovative field of microbiome-based therapy, including the latest therapeutics, efficacy in treating COVID-19 and advice on treating patients with C. diff.

General registration is now open for the premier ID meeting! Register for IDWeek for the opportunity to surround yourself with the ID experts who are advancing the field. Join ID professionals who want to stay current, apply state-of-the-art science to clinical care and excel in their own careers with CME/CPE/CNE/MOC credit available. Find your why and find your way to IDWeek, Oct. 16-19!
https://idweek.org/registration/